Tag: research ethics

Public Registries, Data Repositories and Participant Expectations of Privacy In the domain of clinical trials, managing participant data with both efficacy and ethics is paramount. The advent of numerous public registries and data repositories has created new frameworks for how data is collected, stored, and utilized within clinical trial management. This article directs clinical operations,…

Read More “Public Registries, Data Repositories and Participant Expectations of Privacy” »

Creating Participant Information Sheets on Data Sharing and Future Research In the evolving landscape of clinical research, ethical considerations surrounding data sharing and future research are paramount. This article provides a comprehensive step-by-step guide for clinical trial investigators on developing Participant Information Sheets (PIS) that address privacy, confidentiality, and the secondary use of data. Understanding…

Read More “Participant Information Sheets on Data Sharing and Future Research” »

Data Access Committees and Governance for Secondary Use Requests Data Access Committees and Governance for Secondary Use Requests This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals engaged in clinical research in the US, UK, and EU. It offers an in-depth understanding of Data Access Committees (DACs) and…

Read More “Data Access Committees and Governance for Secondary Use Requests” »

Re-Consent and Broad Consent Models for Secondary Use of Data Re-Consent and Broad Consent Models for Secondary Use of Data In the world of clinical trials, the ethical management of patient data is of paramount importance. As clinical research continues to evolve, the need for robust consent models—especially regarding secondary use of data—becomes increasingly evident….

Read More “Re-Consent and Broad Consent Models for Secondary Use of Data” »

Aligning Privacy Protections With Data Quality and Scientific Value Aligning Privacy Protections With Data Quality and Scientific Value In the landscape of clinical trials, the intersection of privacy rights, data quality, and scientific value is increasingly critical. This guide aims to equip clinical operations, regulatory affairs, and medical affairs professionals with comprehensive knowledge and practical…

Read More “Aligning Privacy Protections With Data Quality and Scientific Value” »

Managing Breaches of Confidentiality: Reporting, CAPA and Communications Managing Breaches of Confidentiality: Reporting, CAPA and Communications In the context of clinical trials, confidentiality is paramount. With sensitive patient information at stake, managing breaches of confidentiality is integral to maintaining integrity and trust in clinical research. This guide provides a step-by-step approach for clinical operations, regulatory…

Read More “Managing Breaches of Confidentiality: Reporting, CAPA and Communications” »

Privacy and Confidentiality in Clinical Trials: Operational Requirements and Pitfalls Privacy and Confidentiality in Clinical Trials: Operational Requirements and Pitfalls In today’s rapidly evolving landscape of clinical research, understanding the operational requirements and potential pitfalls regarding privacy and confidentiality is paramount. This tutorial provides a detailed, step-by-step guide for clinical operations, regulatory affairs, and medical…

Read More “Privacy and Confidentiality in Clinical Trials: Operational Requirements and Pitfalls” »

Designing De-Identification and Coding Strategies for Participant Data Designing De-Identification and Coding Strategies for Participant Data In the landscape of clinical trials, particularly concerning ovarian cancer clinical trials, ensuring the privacy and confidentiality of participant data is paramount. The ethical handling of such sensitive information not only aligns with regulatory mandates but also fosters trust…

Read More “Designing De-Identification and Coding Strategies for Participant Data” »

Secondary Use of Trial Data and Specimens: Ethics and Regulatory Pathways Introduction The secondary use of trial data and specimens involves utilizing data collected during clinical trials for purposes other than those initially intended. This can facilitate further research, enhance the understanding of diseases, and support public health initiatives. However, these practices introduce complex ethical…

Read More “Secondary Use of Trial Data and Specimens: Ethics and Regulatory Pathways” »

Managing Privacy Risks in Decentralized and Technology-Enabled Trials As the landscape of clinical research evolves, the incorporation of technology and decentralized approaches to clinical trials, also known as nucleus clinical trials, has emerged prominently. However, these innovations bring forth critical challenges around privacy risks, which must be adequately managed to ensure compliance with various regulations…

Read More “Managing Privacy Risks in Decentralized and Technology-Enabled Trials” »